Number of the records: 1  

Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors

  1. 1.
    0347297 - BFÚ 2011 RIV SK eng J - Journal Article
    Legartová, Soňa - Harničarová, Andrea - Bártová, Eva - Hájek, R. - Pour, L. - Kozubek, Stanislav
    Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors.
    Neoplasma. Roč. 57, č. 5 (2010), s. 482-487. ISSN 0028-2685. E-ISSN 1338-4317
    R&D Projects: GA MŠMT ME 919; GA ČR(CZ) GAP302/10/1022
    Grant - others:GA MŠk(CZ) LC06027; GA MŠk(CZ) LC535
    Program: LC; LC
    Institutional research plan: CEZ:AV0Z50040507; CEZ:AV0Z50040702
    Keywords : multiple myeloma * RAN * ZHX-2
    Subject RIV: BO - Biophysics
    Impact factor: 1.449, year: 2010

    In myeloma patients we observed significant changes in the expression of RAN, ZHX-2, and CHC1L genes, but it was patient-specific. Our experiments illustrate new methodological approaches and troubleshooting for conducting gene expression studies with clinical samples.
    Permanent Link: http://hdl.handle.net/11104/0188103

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.